Case Type: Mergers & Acquisitions

We are investigating the Board of Directors of Red Hat, Inc. (“Red Hat ” or the “Company”) (NYSE: RHT) for possible breaches of fiduciary duty related to the sale of the company to International Business Machines Corporation (NYSE: IBM) Under the terms of the proposed transaction, shareholders of Red Hat will receive only $190.00 in … Read more

We are investigating the Board of Directors of Newfield Exploration Company (“Newfield” or the “Company”) (NYSE: NFX) for possible breaches of fiduciary duty related to the sale of the company to Encana Corporation (the “Encana”) (NYSE: ECA). Under the terms of the proposed transaction, shareholders of Newfield will receive only 2.6719 Encana common shares for … Read more

We are investigating the Board of Directors of Penn Virginia Corporation (“Penn Virginia”or the “Company”) (NasdaqGS: PVAC) for possible breaches of fiduciary duty related to the sale of the company to Denbury Resources, Inc. (NYSE: DNR). Under the terms of the proposed transaction, shareholders of Penn will receive only 12.4 shares of Denbury common stock … Read more

We are investigating the Board of Directors of Intersections, Inc. (“Intersections ” or the “Company”) (NasdaqGM: INTX) for possible breaches of fiduciary duty related to the sale of the company to a joint venture of iSubscribed, WndrCo, and General Catalyst (“General Catalyst”). Under the terms of the proposed transaction, Intersections shareholders will receive only $3.68 … Read more

We are investigating Datawatch Corporation (“Datawatch” or the “Company”) (NasdaqCM: DWCH) relating to the sale of the Company to Altair Engineering Inc. (NasdaqGS: ALTR). Under the terms of the agreement, Datawatch shareholders are only anticipated to receive $13.10 in cash for each share of Datawatch common stock they own.

We are investigating the Board of Directors of Endocyte, Inc. (“Endocyte” or the “Company”) (NasdaqGS: ECYT) for possible breaches of fiduciary duty related to the sale of the company to affiliates of Novartis AG (“Novartis”). Under the terms of the agreement, Endocyte shareholders are anticipated to receive only $24.00 in cash per share they own.

We are investigating the Board of Directors of Rowan Companies plc. (“As “Rowan” or the “Company”) (NYSE: RDC) for possible breaches of fiduciary duty related to the sale of the company to Ensco plc. (NYSE: ESV) (“Ensco”). Under the terms of the transaction, Rowan shareholders will receive 2.215 Ensco shares for each Rowan share they … Read more

We are investigating JetPay Corporation (“JetPay” or the “Company”) (NasdaqCM: JTPY) relating to the sale of the Company to NCR Corporation (“NCR”) (NYSE: NCR). Under the terms of the agreement, JetPay shareholders are only anticipated to receive $5.05 in cash for each share of JetPay common stock they own

We are investigating the Board of Directors and Officers of Imperva, Inc. (“Imperva” or the “Company”) (NasdaqGS: IMPV) for possible breaches of fiduciary duty relating to the sale of the company to Thoma Bravo, LLC. (“Thoma Bravo”). Under the terms of the proposed transaction, shareholders of Imperva will receive only $55.75 in cash for each … Read more

We are investigating the Board of Directors and Officers of MBT Financial Corp. (“MBT” or the “Company”) (NasdaqGS: MBTF) for possible breaches of fiduciary duty relating to the sale of the company to First Merchants Corporation (“First Merchants”). Under the terms of the proposed transaction, MBT stockholders will receive 0.275 shares of First Merchants for … Read more